Obeticolic Acid

Apejuwe kukuru:

Orukọ API Itọkasi Sipesifikesonu US DMF EU DMF CEP
Obeticolic Acid Biliary cholangitis Ninu Ile      


Alaye ọja

ọja Tags

Apejuwe ọja

Apejuwe

Obeticholic acid (INT-747) jẹ alagbara, yiyan ati agonist FXR ti n ṣiṣẹ ni ẹnu pẹlu EC50 ti 99 nM.Obeticholic acid ni ipa anticholeretic ati egboogi-iredodo.Obeticolic acid tun fa autophagy [1] [2] [3].

 

abẹlẹ

Obeticholic Acid (6alpha-ethyl-chenodeoxycholic acid, 6-ECDCA, INT-747) jẹ agonist ti o lagbara ati yiyan ti FXR pẹlu iye EC50 ti 99 nM [1].

Olugba farnesoid X (FXR) jẹ olugba bile acid iparun kan ti o ni ipa ninu homeostasis bile acid, ẹdọ fibrosis, ẹdọ ẹdọ ati iredodo ifun ati arun inu ọkan ati ẹjẹ [2].

Obeticholic Acid jẹ agonist FXR ti o lagbara ati yiyan pẹlu iṣẹ anticholeretic [1].Obeticholic Acid jẹ itọsẹ bile acid semisynthetic ati ligand FXR ti o lagbara.Ninu awọn eku cholestasis ti estrogen ti o fa, 6-ECDCA ni aabo lodi si cholestasis ti o fa nipasẹ 17a-ethynylestradiol (E217α) [2].Ni cirrhotic portal haipatensonu (PHT) awọn awoṣe eku, INT-747 (30 miligiramu/kg) tun mu FXR ṣiṣẹ ni ipa ọna isamisi isalẹ ati dinku titẹ ẹnu-ọna nipasẹ gbigbe silẹ lapapọ intrahepatic vascular resistance (IHVR) laisi haipatensonu eto eto.Ipa yii ni nkan ṣe pẹlu iṣẹ eNOS ti o pọ si [3].Ninu awoṣe eku Dahl ti haipatensonu ifamọ iyọ ati insulin-resistance (IR), iyọ giga (HS) ounjẹ ti o pọ si ni pataki titẹ ẹjẹ ti eto ati ikosile DDAH tissu isalẹ.INT-747 ṣe imudara ifamọ hisulini ati ṣe idiwọ idinku ti ikosile DDAH [4].

Awọn itọkasi:
[1].Pellicciari R, Fiorucci S, Camaioni E, ati al.6alpha-ethyl-chenodeoxycholic acid (6-ECDCA), agonist FXR ti o lagbara ati yiyan ti a fun ni iṣẹ ṣiṣe anticholestatic.J Med Chem, 2002, 45 (17): 3569-3572.
[2].Fiorucci S, Clerici C, Antonelli E, et al.Awọn ipa aabo ti 6-ethyl chenodeoxycholic acid, ligand olugba ti farnesoid X, ni estrogen-induced cholestasis.J Pharmacol Exp Ther, 2005, 313 (2): 604-612.
[3].Verbeke L, Farre R, Trebicka J, ati al.Obeticholic acid, agonist olugba olugba farnesoid X, ṣe ilọsiwaju haipatensonu ẹnu-ọna nipasẹ awọn ipa ọna ọtọtọ meji ni awọn eku cirrhotic.Ẹdọgba, 2014, 59 (6): 2286-2298.
[4].Ghebremariam YT, Yamada K, Lee JC, ati al.FXR agonist INT-747 ṣe atunṣe ikosile DDAH ati mu ifamọ hisulini pọ si ni awọn eku Dahl ti o jẹ iyọ-giga.PLoS Ọkan, 2013, 8 (4): e60653.

Itọkasi ọja

  • 1. Selina Costa."Ṣiṣepe Ligand aramada kan fun Olugba Farnesoid X nipa lilo Zebrafish Transgenic."Yunifasiti ti Toronto.Oṣu Kẹjọ-2018.
  • 2. Kent, Rebeka."Awọn ipa ti Fenofibrate lori CYP2D6 ati Ilana ti ANG1 ati RNASE4 nipasẹ FXR Agonist Obeticholic Acid."indigo.uic.edu.2017.

 

Ibi ipamọ

Lulú

-20°C

3 odun
 

4°C

ọdun meji 2
Ni epo

-80°C

osu 6
 

-20°C

osu 1

Ilana kemikali

Obeticholic Acid

Jẹmọ Biological Data

Obeticholic Acid2

Jẹmọ Biological Data

Obeticholic Acid3

Ijẹrisi

2018 GMP-2
原料药GMP证书201811(captopril ,thalidomide etc)
GMP-of-PMDA-in-Chanyoo-平成28年08月03日 Nantong-Chanyoo-Pharmatech-Co
FDA-EIR-Letter-201901

Ìṣàkóso didara

Quality management1

Igbero18Awọn iṣẹ akanṣe Igbelewọn Iṣeduro Didara eyiti o ti fọwọsi4, ati6ise agbese ni o wa labẹ alakosile.

Quality management2

Eto iṣakoso didara agbaye ti ilọsiwaju ti fi ipilẹ to lagbara fun tita.

Quality management3

Abojuto didara n ṣiṣẹ nipasẹ gbogbo igbesi aye ọja lati rii daju didara ati ipa itọju ailera.

Quality management4

Ẹgbẹ Aṣoju Iṣeduro Ọjọgbọn ṣe atilẹyin awọn ibeere didara lakoko ohun elo ati iforukọsilẹ.

gbóògì isakoso

cpf5
cpf6

Koria Countec Bottled Packaging Line

cpf7
cpf8

Taiwan CVC Laini Iṣakojọpọ Igo

cpf9
cpf10

Italy CAM Board Packaging Line

cpf11

German Fette Compacting Machine

cpf12

Japan Viswill Tablet Oluwari

cpf14-1

DCS Iṣakoso yara

ALÁGBẸ́NI

International ifowosowopo
International cooperation
Abele ifowosowopo
Domestic cooperation

  • Ti tẹlẹ:
  • Itele:

  • Kọ ifiranṣẹ rẹ nibi ki o si fi si wa

    Awọn ẹka ọja